Publications

Making life better with multiplex molecular diagnostics at the Point of Care

A near-patient, non-sputum based, multiplex RT-PCR assay for tuberculosis diagnosis and disease monitoring

Poster presented at The Union World Conference on Lung Health 2023.

Assessment of QuantuMDx Q-POC Assay for Rapid Detection of SARS-CoV-2 Using Middle Turbinate Swabs

The QuantuMDx Q-POC SARS CoV-2 RT-PCR assay for rapid Detection of COVID-19 at point-of-care: preliminary evaluation of a novel technology

Microfluidic Capture of Mycobacterium tuberculosis from Clinical Samples for Culture-Free Whole-Genome Sequencing

A Novel Microfluidic Dielectrophoresis Technology to Enable Rapid Diagnosis of Mycobacteria tuberculosis in Clinical Samples

Utilising CAPTURE-XT®, a rapid pathogen concentration and sample clean-up technology, as a front-end for Next-Generation Sequencing of Mycobacterium tuberculosis from clinical sputum samples

The aim of this project was to explore the application of CAPTURE-XT®, a microfluidic lab-on-chip pathogen concentration system which utilizes dielectrophoresis to selectively capture and concentrate whole MTB cells from sputum, as a potential front-end for NGS.

Robust detection of SARS-CoV-2 in a multi-centre evaluation of clinical performance using the QuantuMDx SARS-CoV-2 RT-PCR Detection Assay

The QuantuMDx SARS-CoV-2 RT-PCR Detection Assay has demonstrated excellent clinical performance across 5 external validation sites with positive and negative percent agreement of 99.0% and 100% respectively.

A rapid extraction-free methodology for detection of SARS-CoV-2 using the QuantuMDx SARS-CoV-2 RT-PCR Detection Assay for use in the screening of single/pooled saliva samples

QuantuMDx have optimized a methodology for detecting SARS-CoV-2 in saliva specimens without the need for extraction/swabs using commercially available SARS-CoV-2 RT-PCR Detection Assay product. The methodology cuts the time to result to <125 minutes…

CAPTURE-XT explained

Sample cleanup and pathogen concentration

Future development

A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.

Close up of tubercolosis under microscope

Tuberculosis - the challenge

RISK6 explained

Simplified Workflow

Future development

A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.

A supercharged platform, with a fast workflow

A smooth user experience with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing, as simple as a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.